<VariationArchive RecordType="classified" VariationID="12797" VariationName="NM_004959.5(NR5A1):c.1058_1065del (p.Glu353fs)" VariationType="Deletion" Accession="VCV000012797" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-01" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27836" VariationID="12797">
      <GeneList>
        <Gene Symbol="NR5A1" FullName="nuclear receptor subfamily 5 group A member 1" GeneID="2516" HGNC_ID="HGNC:7983" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q33.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="124481236" stop="124507399" display_start="124481236" display_stop="124507399" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="127243514" stop="127269698" display_start="127243514" display_stop="127269698" Strand="-" />
          </Location>
          <OMIM>184757</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR5A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR5A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004959.5(NR5A1):c.1058_1065del (p.Glu353fs)</Name>
      <CanonicalSPDI>NC_000009.12:124491153:CACCAGCTC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q33.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="124491154" stop="124491161" display_start="124491154" display_stop="124491161" variantLength="8" positionVCF="124491153" referenceAlleleVCF="GCACCAGCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="127253433" stop="127253440" display_start="127253433" display_stop="127253440" variantLength="8" positionVCF="127253432" referenceAlleleVCF="GCACCAGCT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>E353fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.127253434_127253441del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.127253434_127253441del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.124491155_124491162del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.124491155_124491162del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008176.1" sequenceAccession="NG_008176" sequenceVersion="1" change="g.21260_21267del">
            <Expression>NG_008176.1:g.21260_21267del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004959.5" sequenceAccession="NM_004959" sequenceVersion="5" change="c.1058_1065del" MANESelect="true">
            <Expression>NM_004959.5:c.1058_1065del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004950.2" sequenceAccession="NP_004950" sequenceVersion="2" change="p.Glu353fs">
            <Expression>NP_004950.2:p.Glu353fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="184757.0004" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for allelic variant 184757.0004 based on the context of the deletion reported in Figure 1 of the paper by Correa et al., 2004 (PubMed 15070943).  Please note that the sequence was reported as delATCTGGTG, whereas in current annotation the deletion is delAGCTGGTG.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004959.5(NR5A1):c.1058_1065del (p.Glu353fs) AND 46,XY sex reversal 3" Accession="RCV000013641" Version="25">
        <ClassifiedConditionList TraitSetID="6711">
          <ClassifiedCondition DB="MedGen" ID="C3489793">46,XY sex reversal 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-04-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15070943</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6711" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6630" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">46,XY SEX REVERSAL, PARTIAL OR COMPLETE, NR5A1-RELATED</ElementValue>
                <XRef Type="MIM" ID="612965" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR5A1-Related 46,XY CGD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR5A1-related 46,XY complete gonadal dysgenesis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SEX REVERSAL, XY, WITH OR WITHOUT ADRENAL FAILURE</ElementValue>
                <XRef Type="MIM" ID="612965" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">46,XY GONADAL DYSGENESIS, PARTIAL OR COMPLETE, WITH OR WITHOUT ADRENAL FAILURE</ElementValue>
                <XRef Type="MIM" ID="612965" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DISORDER OF SEX DEVELOPMENT, 46,XY, NR5A1-RELATED</ElementValue>
                <XRef Type="MIM" ID="612965" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">46,XY sex reversal 3</ElementValue>
                <XRef ID="MONDO:0013066" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SRXY3</ElementValue>
                <XRef ID="GTR000528538" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="612965" DB="OMIM" />
              </Symbol>
              <Citation Type="Position Statement" Abbrev="LWPES/ESPE, 2006">
                <ID Source="PubMed">18947601</ID>
              </Citation>
              <XRef ID="C3489793" DB="MedGen" />
              <XRef ID="MONDO:0013066" DB="MONDO" />
              <XRef Type="MIM" ID="612965" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33888" SubmissionDate="2016-08-09" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="184757.0004_46,XY SEX REVERSAL 3" title="NR5A1, 8-BP DEL, NT1058_46,XY SEX REVERSAL 3" />
        <ClinVarAccession Accession="SCV000033888" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Correa et al. (2004) reported a novel 8-bp microdeletion of SF1, isolated from a 46,XY patient who presented with gonadal agenesis but normal adrenal function (SRXY3; 612965), that causes premature termination upstream of sequences encoding the activation function-2 domain. In cell transfection experiments, the mutated protein possessed no intrinsic transcriptional activity but rather inhibited the function of the wildtype protein in most cell types. The authors stated that this was the first example of an apparent dominant-negative effect of an SF1 mutation in humans. The authors concluded that these findings, which defined an SF1 mutation that apparently differentially affects its transcriptional activity in vivo in the adrenal cortex and the gonads, may be relevant to patients who present with 46,XY sex reversal but normal adrenal functions.</Attribute>
              <Citation>
                <ID Source="PubMed">15070943</ID>
              </Citation>
              <XRef DB="OMIM" ID="612965" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR5A1" />
          </GeneList>
          <Name>NR5A1, 8-BP DEL, NT1058</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">8-BP DEL, NT1058</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="184757.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">46,XY SEX REVERSAL 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33888" TraitType="Disease" MappingType="Name" MappingValue="46,XY SEX REVERSAL 3" MappingRef="Preferred">
        <MedGen CUI="C3489793" Name="46,XY sex reversal 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

